US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Immuneering Corp

5.30

+0.05000.95%

Post-market: 5.24-0.0600-1.13%19:50 EDT

Volume:445.57K

Turnover:2.38M

Market Cap:342.22M

PE:-5.41

High:5.43

Open:5.31

Low:5.28

Close:5.25

52wk High:10.08

52wk Low:3.86

Shares:64.57M

Float Shares:49.21M

Volume Ratio:0.81

T/O Rate:0.91%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.9796

EPS(LYR):-1.2729

ROE:-52.15%

ROA:-32.77%

PB:1.79

PE(LYR):-4.16

Loading ...

Overview Company News Filings

Immuneering initiated with an Overweight at Cantor Fitzgerald

Kalaris Appoints Laurie Keating to Board, Replacing Morana Jovan-embiricos

Top Executive Makes Bold Insider Move on Immuneering Stock

Immuneering CEO Benjamin Zeskind Acquires 2,400 Shares for $10,948.08

Immuneering Chief Scientific Officer Brett Matthew Hall buys $25,045 of common shares

Mizuho Securities Reaffirms Their Buy Rating on Immuneering (IMRX)

Immuneering Appoints Veteran Biotech Leader as New CFO

Immuneering Names Andrew Gengos as CFO

MT Newswires Live

Immuneering Names Andrew Gengos Chief Financial Officer

Immuneering - Appoints Andrew Gengos as Chief Financial Officer Effective July 16, 2026

THOMSON REUTERS

Press Release: Immuneering Appoints Andrew Gengos as Chief Financial Officer

Immuneering Shareholders Approve Directors and Auditor at Meeting

Immuneering's Phase 3 Trial of Atebimetinib Plus mGnP to Treat Pancreatic Cancer Doses First Patient

MT Newswires Live

Immuneering doses first patient in Phase 3 MAPKeeper 301 trial for first-line metastatic pancreatic cancer

Immuneering - Topline Data From Phase 3 Trial Expected in Mid-2028

THOMSON REUTERS

Immuneering Buy Rating Reaffirmed as Analyst Sees ASCO Sell-Off as Overdone; $11 Price Target Maintained

Immuneering Advances Atebimetinib With Positive Phase 2a Results

Immuneering - 17.3 Month Median Overall Survival Observed in 320 Mg ITT Population as of April 24, 2026 - SEC Filing

THOMSON REUTERS

Immuneering - Announces Updated Phase 2a Data for Atebimetinib in Pancreatic Cancer - SEC Filing

THOMSON REUTERS

Immuneering says atebimetinib plus chemo posts 17.3-month median survival in Phase 2a first-line pancreatic cancer study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/IMRX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMRX\",,,,,undefined,":{"symbol":"IMRX","market":"US","secType":"STK","nameCN":"Immuneering Corp","latestPrice":5.3,"timestamp":1787342400000,"preClose":5.25,"halted":0,"volume":445565,"hourTrading":{"tag":"盘后","latestPrice":5.24,"preClose":5.3,"latestTime":"19:50 EDT","volume":4476,"amount":23781.1937,"timestamp":1787356218129,"change":-0.06,"changeRate":-0.011321,"amplitude":0.02},"delay":0,"changeRate":0.00952380952380949,"floatShares":49210000,"shares":64569967,"eps":-0.979559,"marketStatus":"Market Closed","change":0.05,"latestTime":"08-21 16:00:00 EDT","open":5.31,"high":5.43,"low":5.281277,"amount":2378383.19576,"amplitude":0.028328,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.979559,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":5.25,"preHourTrading":{"tag":"盘前","latestPrice":5.26,"preClose":5.25,"latestTime":"08:24 EDT","volume":2,"amount":10.51,"timestamp":1787315054622,"change":0.01,"changeRate":0.001905,"amplitude":0.001905},"postHourTrading":{"tag":"盘后","latestPrice":5.24,"preClose":5.3,"latestTime":"19:50 EDT","volume":4476,"amount":23781.1937,"timestamp":1787356218129,"change":-0.06,"changeRate":-0.011321,"amplitude":0.02},"volumeRatio":0.8110240975014792,"impliedVol":1.0673,"impliedVolPercentile":0.2691},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMRX\",,,,,undefined,":{"symbol":"IMRX","floatShares":49210000,"roa":"-32.77%","roe":"-52.15%","lyrEps":-1.27295,"volumeRatio":0.8110240975014792,"shares":64569967,"dividePrice":0,"high":5.43,"amplitude":0.028328,"preClose":5.25,"low":5.281277,"week52Low":3.86,"pbRate":"1.79","psRate":"752133.68","week52High":10.08,"institutionHeld":0,"latestPrice":5.3,"eps":-0.979559,"divideRate":0,"volume":445565,"delay":0,"ttmEps":-0.979559,"open":5.31,"prevYearClose":6.58,"prevWeekClose":5.06,"prevMonthClose":4.13,"prevQuarterClose":4.99,"fiveDayClose":5.06,"twentyDayClose":4.32,"sixtyDayClose":5.335},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-02-08","symbol":"IMRX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1644296400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-09-09","symbol":"IMRX","fiscalQuarterEnding":"2021/06","expectedEps":-1.78,"name":null,"time":"","type":"earning","dateTimestamp":1631160000000,"reportTimeType":"","actualEps":-1.61}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":8,"updateTime":1786075200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMRX","date":"2026-08-21","current":-5.410598,"percent":0.272652,"low":-35.76593,"twenty":-6.401892,"median":-4.246328,"eighty":-1.165266,"high":-0.544763,"avg":-5.593309,"sd":6.428055,"marketCap":339661360},"quantilePoints":[{"date":"2021-08-27","current":-32.375276,"twenty":-36.475658,"median":-34.52026,"eighty":-22.529012,"marketCap":649733882},{"date":"2021-09-03","current":-34.404807,"twenty":-36.171837,"median":-34.307584,"eighty":-25.783553,"marketCap":690464197},{"date":"2021-09-10","current":-22.010777,"twenty":-35.957946,"median":-32.776321,"eighty":-24.276106,"marketCap":538214828},{"date":"2021-09-17","current":-30.210454,"twenty":-35.824264,"median":-31.84055,"eighty":-25.184572,"marketCap":738716062},{"date":"2021-09-24","current":-29.160302,"twenty":-35.381899,"median":-31.06967,"eighty":-26.168957,"marketCap":713037379},{"date":"2021-10-01","current":-30.655974,"twenty":-34.823563,"median":-31.016632,"eighty":-26.847844,"marketCap":749610049},{"date":"2021-10-08","current":-29.393669,"twenty":-34.79613,"median":-30.963594,"eighty":-27.123376,"marketCap":718743753},{"date":"2021-10-15","current":-26.370502,"twenty":-34.757241,"median":-30.737841,"eighty":-25.579175,"marketCap":644820271},{"date":"2021-10-22","current":-27.420655,"twenty":-34.594392,"median":-30.019518,"eighty":-25.579175,"marketCap":670498954},{"date":"2021-10-29","current":-28.746605,"twenty":-34.370779,"median":-29.565885,"eighty":-25.859215,"marketCap":702921534},{"date":"2021-11-05","current":-31.674304,"twenty":-34.314876,"median":-29.74372,"eighty":-26.166836,"marketCap":774510591},{"date":"2021-11-12","current":-25.289652,"twenty":-34.283278,"median":-29.565885,"eighty":-26.166836,"marketCap":722963518},{"date":"2021-11-19","current":-22.558333,"twenty":-33.710006,"median":-28.972469,"eighty":-25.187144,"marketCap":644882421},{"date":"2021-11-26","current":-20.453131,"twenty":-32.879093,"median":-28.778428,"eighty":-24.841544,"marketCap":584700312},{"date":"2021-12-03","current":-17.576626,"twenty":-32.696112,"median":-28.497326,"eighty":-23.741458,"marketCap":502468724},{"date":"2021-12-10","current":-19.636457,"twenty":-32.324185,"median":-28.163187,"eighty":-22.296998,"marketCap":561353804},{"date":"2021-12-17","current":-19.309788,"twenty":-32.100427,"median":-27.505516,"eighty":-21.262189,"marketCap":552015201},{"date":"2021-12-23","current":-18.874241,"twenty":-32.022843,"median":-27.430931,"eighty":-20.552946,"marketCap":539564079},{"date":"2021-12-31","current":-14.887633,"twenty":-31.674304,"median":-27.177075,"eighty":-20.40776,"marketCap":425597617},{"date":"2022-01-07","current":-14.243147,"twenty":-31.658256,"median":-26.71902,"eighty":-19.482197,"marketCap":407173478},{"date":"2022-01-14","current":-11.969031,"twenty":-31.51519,"median":-26.42354,"eighty":-19.028489,"marketCap":342162587},{"date":"2022-01-21","current":-11.103578,"twenty":-31.481245,"median":-26.031059,"eighty":-18.640116,"marketCap":317421599},{"date":"2022-01-28","current":-9.206947,"twenty":-31.447301,"median":-25.379254,"eighty":-18.098783,"marketCap":263201990},{"date":"2022-02-04","current":-9.022808,"twenty":-31.303678,"median":-25.09002,"eighty":-15.312994,"marketCap":257937950},{"date":"2022-02-11","current":-8.746599,"twenty":-31.202956,"median":-24.614944,"eighty":-14.27445,"marketCap":250041890},{"date":"2022-02-18","current":-7.669387,"twenty":-31.093007,"median":-23.973184,"eighty":-13.003892,"marketCap":219247257},{"date":"2022-02-25","current":-7.227453,"twenty":-31.006024,"median":-23.297074,"eighty":-12.195522,"marketCap":206613562},{"date":"2022-03-04","current":-6.104206,"twenty":-30.912677,"median":-22.394998,"eighty":-11.324544,"marketCap":174502919},{"date":"2022-03-11","current":-5.104662,"twenty":-30.843317,"median":-21.805179,"eighty":-10.260222,"marketCap":171188670},{"date":"2022-03-18","current":-5.505799,"twenty":-30.766019,"median":-21.218553,"eighty":-9.206947,"marketCap":184641093},{"date":"2022-03-25","current":-5.702435,"twenty":-30.685675,"median":-20.552946,"eighty":-9.004394,"marketCap":191235417},{"date":"2022-04-01","current":-5.851878,"twenty":-30.388662,"median":-20.434983,"eighty":-8.728185,"marketCap":196247104},{"date":"2022-04-08","current":-5.560857,"twenty":-30.095892,"median":-19.881459,"eighty":-7.906926,"marketCap":186487503},{"date":"2022-04-14","current":-5.026008,"twenty":-29.909199,"median":-19.636457,"eighty":-7.155639,"marketCap":168550940},{"date":"2022-04-22","current":-4.632737,"twenty":-29.741472,"median":-19.332473,"eighty":-6.57376,"marketCap":155362291},{"date":"2022-04-29","current":-3.909117,"twenty":-29.600328,"median":-19.028489,"eighty":-6.236786,"marketCap":131095176},{"date":"2022-05-06","current":-3.863096,"twenty":-29.300322,"median":-18.77442,"eighty":-6.076585,"marketCap":129551818},{"date":"2022-05-13","current":-3.301241,"twenty":-29.085169,"median":-18.248113,"eighty":-5.773224,"marketCap":132718053},{"date":"2022-05-20","current":-2.868076,"twenty":-28.958498,"median":-17.902974,"eighty":-5.560857,"marketCap":115303756},{"date":"2022-05-27","current":-3.032154,"twenty":-28.873896,"median":-15.642603,"eighty":-5.43973,"marketCap":121900081},{"date":"2022-06-03","current":-3.117474,"twenty":-28.772063,"median":-15.136221,"eighty":-5.357929,"marketCap":125330170},{"date":"2022-06-10","current":-3.248736,"twenty":-28.702053,"median":-14.560786,"eighty":-5.169159,"marketCap":130607230},{"date":"2022-06-17","current":-3.019028,"twenty":-28.513237,"median":-14.243147,"eighty":-5.057469,"marketCap":121372375},{"date":"2022-06-24","current":-2.966523,"twenty":-28.470807,"median":-13.018623,"eighty":-4.797911,"marketCap":119261551},{"date":"2022-07-01","current":-3.281552,"twenty":-28.322301,"median":-12.535258,"eighty":-4.516125,"marketCap":131926495},{"date":"2022-07-08","current":-4.77794,"twenty":-28.19501,"median":-11.72965,"eighty":-4.342773,"marketCap":192084976},{"date":"2022-07-15","current":-4.764813,"twenty":-27.798285,"median":-11.342958,"eighty":-4.376588,"marketCap":191557270},{"date":"2022-07-22","current":-4.679493,"twenty":-27.596741,"median":-11.177233,"eighty":-4.47804,"marketCap":188127181},{"date":"2022-07-29","current":-4.279144,"twenty":-27.467328,"median":-9.768571,"eighty":-4.342843,"marketCap":172032149},{"date":"2022-08-05","current":-4.200386,"twenty":-27.441339,"median":-9.354258,"eighty":-4.248161,"marketCap":168865913},{"date":"2022-08-12","current":-3.583967,"twenty":-27.424765,"median":-9.206947,"eighty":-4.220076,"marketCap":156770256},{"date":"2022-08-19","current":-4.036488,"twenty":-27.284877,"median":-8.99979,"eighty":-4.217662,"marketCap":176564480},{"date":"2022-08-26","current":-3.638269,"twenty":-27.191847,"median":-8.820255,"eighty":-4.112624,"marketCap":159145562},{"date":"2022-09-02","current":-4.489009,"twenty":-26.964607,"median":-8.663737,"eighty":-4.062597,"marketCap":196358704},{"date":"2022-09-09","current":-5.351815,"twenty":-26.847844,"median":-8.102113,"eighty":-4.089364,"marketCap":234099692},{"date":"2022-09-16","current":-7.409278,"twenty":-26.701741,"median":-7.540489,"eighty":-4.110182,"marketCap":324097431},{"date":"2022-09-23","current":-6.184454,"twenty":-26.518292,"median":-7.478664,"eighty":-4.129108,"marketCap":270521064},{"date":"2022-09-30","current":-8.640135,"twenty":-26.430952,"median":-7.511849,"eighty":-4.171405,"marketCap":377937721},{"date":"2022-10-07","current":-7.753194,"twenty":-26.391717,"median":-7.604938,"eighty":-4.197576,"marketCap":339141042},{"date":"2022-10-14","current":-7.759227,"twenty":-26.166836,"median":-7.710958,"eighty":-4.204957,"marketCap":339404965},{"date":"2022-10-21","current":-7.825597,"twenty":-25.859215,"median":-7.75621,"eighty":-4.215247,"marketCap":342308118},{"date":"2022-10-28","current":-8.145379,"twenty":-25.579175,"median":-7.831631,"eighty":-4.220076,"marketCap":356296036},{"date":"2022-11-04","current":-6.226689,"twenty":-25.361334,"median":-7.837664,"eighty":-4.222148,"marketCap":272368525},{"date":"2022-11-11","current":-4.159708,"twenty":-25.187144,"median":-7.759227,"eighty":-4.222148,"marketCap":199883821},{"date":"2022-11-18","current":-3.846494,"twenty":-25.101534,"median":-7.732076,"eighty":-4.197576,"marketCap":184833124},{"date":"2022-11-25","current":-3.610209,"twenty":-25.039205,"median":-7.656988,"eighty":-4.124428,"marketCap":173479089},{"date":"2022-12-02","current":-3.25853,"twenty":-24.902263,"median":-7.535984,"eighty":-4.049542,"marketCap":156580060},{"date":"2022-12-09","current":-2.846405,"twenty":-24.654192,"median":-7.415311,"eighty":-3.946191,"marketCap":136776511},{"date":"2022-12-16","current":-2.302401,"twenty":-24.266189,"median":-7.240336,"eighty":-3.838309,"marketCap":110635827},{"date":"2022-12-23","current":-2.401311,"twenty":-24.011725,"median":-7.167608,"eighty":-3.788803,"marketCap":115388678},{"date":"2022-12-30","current":-2.665071,"twenty":-23.915253,"median":-6.893039,"eighty":-3.65307,"marketCap":128062950},{"date":"2023-01-06","current":-2.165026,"twenty":-23.683527,"median":-6.748692,"eighty":-3.620168,"marketCap":104034644},{"date":"2023-01-13","current":-2.434281,"twenty":-23.297074,"median":-6.444863,"eighty":-3.571744,"marketCap":116972962},{"date":"2023-01-20","current":-2.384826,"twenty":-23.091187,"median":-6.389597,"eighty":-3.539873,"marketCap":114596536},{"date":"2023-01-27","current":-2.445271,"twenty":-22.654609,"median":-6.277203,"eighty":-3.410189,"marketCap":117501057},{"date":"2023-02-03","current":-2.181511,"twenty":-22.296998,"median":-6.214689,"eighty":-3.365467,"marketCap":104826786},{"date":"2023-02-10","current":-2.077107,"twenty":-22.054954,"median":-6.163676,"eighty":-3.32093,"marketCap":99809886},{"date":"2023-02-17","current":-2.522201,"twenty":-21.846299,"median":-6.058171,"eighty":-3.281552,"marketCap":121197719},{"date":"2023-02-24","current":-2.577151,"twenty":-21.548222,"median":-5.985345,"eighty":-3.232985,"marketCap":123838193},{"date":"2023-03-03","current":-2.79695,"twenty":-21.290871,"median":-5.847945,"eighty":-3.116748,"marketCap":134400085},{"date":"2023-03-10","current":-3.940801,"twenty":-21.215562,"median":-5.7103,"eighty":-3.10326,"marketCap":199063900},{"date":"2023-03-17","current":-4.223408,"twenty":-20.877378,"median":-5.560857,"eighty":-3.116748,"marketCap":213339399},{"date":"2023-03-24","current":-5.427105,"twenty":-20.595727,"median":-5.505799,"eighty":-3.117474,"marketCap":274142450},{"date":"2023-03-31","current":-5.081696,"twenty":-20.542057,"median":-5.445473,"eighty":-3.164729,"marketCap":256694618},{"date":"2023-04-06","current":-4.375178,"twenty":-20.502131,"median":-5.427125,"eighty":-3.201482,"marketCap":221005871},{"date":"2023-04-14","current":-6.463332,"twenty":-20.438612,"median":-5.432339,"eighty":-3.225109,"marketCap":326485946},{"date":"2023-04-21","current":-6.832312,"twenty":-20.413204,"median":-5.498193,"eighty":-3.252654,"marketCap":345124456},{"date":"2023-04-28","current":-6.132304,"twenty":-20.19724,"median":-5.560857,"eighty":-3.267739,"marketCap":309764542},{"date":"2023-05-05","current":-4.649577,"twenty":-19.866941,"median":-5.533328,"eighty":-3.281552,"marketCap":234866707},{"date":"2023-05-11","current":-4.111377,"twenty":-19.803422,"median":-5.498193,"eighty":-3.28549,"marketCap":210590323},{"date":"2023-05-18","current":-4.945072,"twenty":-19.678198,"median":-5.458607,"eighty":-3.297303,"marketCap":253293360},{"date":"2023-05-26","current":-3.72879,"twenty":-19.513049,"median":-5.429742,"eighty":-3.311742,"marketCap":190993723},{"date":"2023-06-02","current":-5.379051,"twenty":-19.431382,"median":-5.427105,"eighty":-3.316992,"marketCap":275522339},{"date":"2023-06-07","current":-5.281977,"twenty":-19.380567,"median":-5.411414,"eighty":-3.319617,"marketCap":270550068},{"date":"2023-06-15","current":-5.321949,"twenty":-19.337011,"median":-5.419259,"eighty":-3.32093,"marketCap":272597473},{"date":"2023-06-23","current":-6.446867,"twenty":-19.309788,"median":-5.427145,"eighty":-3.32093,"marketCap":330217326},{"date":"2023-06-30","current":-5.470415,"twenty":-19.204528,"median":-5.432339,"eighty":-3.331431,"marketCap":280202124},{"date":"2023-07-07","current":-5.658853,"twenty":-19.043008,"median":-5.458607,"eighty":-3.349234,"marketCap":289854180},{"date":"2023-07-14","current":-5.413313,"twenty":-19.015785,"median":-5.464511,"eighty":-3.358014,"marketCap":277277258},{"date":"2023-07-21","current":-5.83016,"twenty":-18.946824,"median":-5.498966,"eighty":-3.361598,"marketCap":298628777},{"date":"2023-07-28","current":-5.35621,"twenty":-18.834312,"median":-5.502382,"eighty":-3.366756,"marketCap":274352393},{"date":"2023-08-04","current":-5.856075,"twenty":-18.640116,"median":-5.538938,"eighty":-3.368463,"marketCap":299956153},{"date":"2023-08-11","current":-5.640407,"twenty":-18.451374,"median":-5.556069,"eighty":-3.380171,"marketCap":292640150},{"date":"2023-08-18","current":-4.969198,"twenty":-18.244355,"median":-5.538938,"eighty":-3.402313,"marketCap":257815972},{"date":"2023-08-25","current":-5.454273,"twenty":-18.229322,"median":-5.536059,"eighty":-3.424628,"marketCap":282983025},{"date":"2023-09-01","current":-5.082007,"twenty":-18.098783,"median":-5.505799,"eighty":-3.473171,"marketCap":263668775},{"date":"2023-09-08","current":-4.732301,"twenty":-17.576626,"median":-5.490588,"eighty":-3.478329,"marketCap":245525085},{"date":"2023-09-15","current":-4.320552,"twenty":-16.848713,"median":-5.45644,"eighty":-3.500309,"marketCap":224162354},{"date":"2023-09-22","current":-4.360034,"twenty":-15.642603,"median":-5.442993,"eighty":-3.543057,"marketCap":226210835},{"date":"2023-09-29","current":-4.416439,"twenty":-15.41427,"median":-5.427145,"eighty":-3.548423,"marketCap":229137237},{"date":"2023-10-06","current":-4.207743,"twenty":-15.180414,"median":-5.412363,"eighty":-3.550464,"marketCap":218309551},{"date":"2023-10-13","current":-3.522434,"twenty":-14.937351,"median":-5.379051,"eighty":-3.550464,"marketCap":182753773},{"date":"2023-10-20","current":-3.384244,"twenty":-14.860012,"median":-5.35907,"eighty":-3.513584,"marketCap":175584090},{"date":"2023-10-27","current":-3.023258,"twenty":-14.841598,"median":-5.356356,"eighty":-3.478329,"marketCap":156855120},{"date":"2023-11-03","current":-3.384244,"twenty":-14.279974,"median":-5.34622,"eighty":-3.412814,"marketCap":175584090},{"date":"2023-11-10","current":-2.947163,"twenty":-14.252354,"median":-5.321949,"eighty":-3.384244,"marketCap":152172878},{"date":"2023-11-17","current":-2.913665,"twenty":-14.243147,"median":-5.300305,"eighty":-3.384244,"marketCap":150443281},{"date":"2023-11-24","current":-4.364829,"twenty":-13.705461,"median":-5.294869,"eighty":-3.382454,"marketCap":225372231},{"date":"2023-12-01","current":-3.718608,"twenty":-13.129106,"median":-5.237177,"eighty":-3.384244,"marketCap":192005433},{"date":"2023-12-08","current":-4.631254,"twenty":-12.974429,"median":-5.212533,"eighty":-3.384244,"marketCap":239128718},{"date":"2023-12-15","current":-4.381835,"twenty":-12.812387,"median":-5.168731,"eighty":-3.384244,"marketCap":226250305},{"date":"2023-12-22","current":-3.956689,"twenty":-12.49751,"median":-5.15972,"eighty":-3.384244,"marketCap":204298464},{"date":"2023-12-29","current":-4.421515,"twenty":-12.271019,"median":-5.151886,"eighty":-3.384244,"marketCap":228299143},{"date":"2024-01-05","current":-3.837648,"twenty":-12.044528,"median":-5.118331,"eighty":-3.384244,"marketCap":198151949},{"date":"2024-01-12","current":-3.531543,"twenty":-11.586022,"median":-5.092178,"eighty":-3.384244,"marketCap":182346623},{"date":"2024-01-19","current":-3.293462,"twenty":-11.446076,"median":-5.084468,"eighty":-3.384244,"marketCap":170053593},{"date":"2024-01-26","current":-3.514538,"twenty":-11.37242,"median":-5.081696,"eighty":-3.384244,"marketCap":181468550},{"date":"2024-02-02","current":-3.256616,"twenty":-11.315338,"median":-5.051704,"eighty":-3.384244,"marketCap":168151100},{"date":"2024-02-09","current":-3.452183,"twenty":-11.269303,"median":-5.026008,"eighty":-3.380663,"marketCap":178248946},{"date":"2024-02-16","current":-3.797968,"twenty":-11.162502,"median":-4.979499,"eighty":-3.384244,"marketCap":196103110},{"date":"2024-02-23","current":-3.639247,"twenty":-10.897342,"median":-4.964988,"eighty":-3.384244,"marketCap":187907756},{"date":"2024-03-01","current":-3.514538,"twenty":-10.260222,"median":-4.924075,"eighty":-3.384244,"marketCap":181468550},{"date":"2024-03-08","current":-3.658244,"twenty":-9.709646,"median":-4.89778,"eighty":-3.384244,"marketCap":195612256},{"date":"2024-03-15","current":-1.58816,"twenty":-9.573383,"median":-4.876386,"eighty":-3.370913,"marketCap":84921488},{"date":"2024-03-22","current":-1.495061,"twenty":-9.38372,"median":-4.839647,"eighty":-3.363712,"marketCap":79943332},{"date":"2024-03-28","current":-1.330768,"twenty":-9.206947,"median":-4.791108,"eighty":-3.351606,"marketCap":71158350},{"date":"2024-04-05","current":-1.286957,"twenty":-9.206947,"median":-4.774314,"eighty":-3.322939,"marketCap":68815689},{"date":"2024-04-12","current":-1.139094,"twenty":-9.203264,"median":-4.742734,"eighty":-3.314805,"marketCap":60909205},{"date":"2024-04-19","current":-0.969325,"twenty":-9.160911,"median":-4.686056,"eighty":-3.281552,"marketCap":51831391},{"date":"2024-04-26","current":-0.793024,"twenty":-9.045594,"median":-4.679711,"eighty":-3.256999,"marketCap":42404297},{"date":"2024-05-03","current":-0.865117,"twenty":-9.02559,"median":-4.67293,"eighty":-3.222326,"marketCap":46259233},{"date":"2024-05-10","current":-0.853881,"twenty":-9.013601,"median":-4.631996,"eighty":-3.197538,"marketCap":46259233},{"date":"2024-05-17","current":-0.842934,"twenty":-8.960201,"median":-4.600736,"eighty":-3.119794,"marketCap":45666166},{"date":"2024-05-24","current":-0.777251,"twenty":-8.87918,"median":-4.556776,"eighty":-3.079409,"marketCap":42107764},{"date":"2024-05-31","current":-0.755356,"twenty":-8.820255,"median":-4.537707,"eighty":-3.038717,"marketCap":40921629},{"date":"2024-06-07","current":-0.771777,"twenty":-8.746599,"median":-4.512325,"eighty":-2.993026,"marketCap":41811230},{"date":"2024-06-14","current":-0.925038,"twenty":-8.709772,"median":-4.502289,"eighty":-2.980329,"marketCap":50114169},{"date":"2024-06-21","current":-0.771777,"twenty":-8.664307,"median":-4.495207,"eighty":-2.939832,"marketCap":41811230},{"date":"2024-06-28","current":-0.782724,"twenty":-8.640135,"median":-4.489009,"eighty":-2.920581,"marketCap":42404297},{"date":"2024-07-05","current":-0.618516,"twenty":-8.629554,"median":-4.472533,"eighty":-2.895554,"marketCap":33508291},{"date":"2024-07-12","current":-0.717041,"twenty":-8.545779,"median":-4.46206,"eighty":-2.873326,"marketCap":38845895},{"date":"2024-07-15","current":-0.678726,"twenty":-8.525496,"median":-4.461562,"eighty":-2.868076,"marketCap":36770160},{"date":"2024-08-02","current":-0.738935,"twenty":-8.503775,"median":-4.455922,"eighty":-2.850739,"marketCap":40032029},{"date":"2024-08-09","current":-0.592364,"twenty":-8.404824,"median":-4.42544,"eighty":-2.804643,"marketCap":33211757},{"date":"2024-08-16","current":-0.571208,"twenty":-8.326387,"median":-4.418977,"eighty":-2.748595,"marketCap":32025623},{"date":"2024-08-23","current":-0.555341,"twenty":-8.193648,"median":-4.410178,"eighty":-2.718038,"marketCap":31136022},{"date":"2024-08-30","current":-0.61352,"twenty":-8.144091,"median":-4.381439,"eighty":-2.669467,"marketCap":34397891},{"date":"2024-09-06","current":-0.629387,"twenty":-8.138941,"median":-4.377791,"eighty":-2.637596,"marketCap":35287492},{"date":"2024-09-13","current":-0.756322,"twenty":-8.109177,"median":-4.364829,"eighty":-2.553047,"marketCap":42404297},{"date":"2024-09-20","current":-1.27993,"twenty":-8.065285,"median":-4.359401,"eighty":-2.472746,"marketCap":71761119},{"date":"2024-09-27","current":-1.38042,"twenty":-8.006605,"median":-4.328077,"eighty":-2.428786,"marketCap":77395256},{"date":"2024-10-04","current":-1.253485,"twenty":-7.946269,"median":-4.308243,"eighty":-2.401311,"marketCap":70278451},{"date":"2024-10-11","current":-1.17415,"twenty":-7.940236,"median":-4.278792,"eighty":-2.379331,"marketCap":65830448},{"date":"2024-10-18","current":-1.105394,"twenty":-7.928168,"median":-4.243224,"eighty":-2.324381,"marketCap":61975511},{"date":"2024-10-25","current":-1.137127,"twenty":-7.922135,"median":-4.223408,"eighty":-2.296906,"marketCap":63754713},{"date":"2024-10-31","current":-1.015481,"twenty":-7.922135,"median":-4.220076,"eighty":-2.247451,"marketCap":56934441},{"date":"2024-11-08","current":-1.02077,"twenty":-7.917308,"median":-4.210694,"eighty":-2.203491,"marketCap":57230975},{"date":"2024-11-15","current":-0.990682,"twenty":-7.877486,"median":-4.200386,"eighty":-2.163927,"marketCap":57527508},{"date":"2024-11-22","current":-1.077494,"twenty":-7.863006,"median":-4.18227,"eighty":-2.124364,"marketCap":62568579},{"date":"2024-11-29","current":-1.117565,"twenty":-7.850938,"median":-4.154565,"eighty":-1.653919,"marketCap":64895436},{"date":"2024-12-06","current":-1.144301,"twenty":-7.836458,"median":-4.134218,"eighty":-1.535604,"marketCap":66447958},{"date":"2024-12-13","current":-1.053398,"twenty":-7.828011,"median":-4.114285,"eighty":-1.501633,"marketCap":61169382},{"date":"2024-12-20","current":-0.983885,"twenty":-7.785775,"median":-4.110253,"eighty":-1.404904,"marketCap":57132824},{"date":"2024-12-27","current":-1.16569,"twenty":-7.756814,"median":-4.094935,"eighty":-1.382465,"marketCap":67689976},{"date":"2025-01-03","current":-1.181731,"twenty":-7.753194,"median":-4.069124,"eighty":-1.319715,"marketCap":68621490},{"date":"2025-01-10","current":-1.06944,"twenty":-7.753194,"median":-4.066404,"eighty":-1.306374,"marketCap":62100896},{"date":"2025-01-17","current":-1.048051,"twenty":-7.710958,"median":-4.027437,"eighty":-1.27993,"marketCap":60858878},{"date":"2025-01-24","current":-1.149648,"twenty":-7.677701,"median":-4.004689,"eighty":-1.260248,"marketCap":66758463},{"date":"2025-01-31","current":-1.037357,"twenty":-7.649549,"median":-3.985032,"eighty":-1.226534,"marketCap":60237869},{"date":"2025-02-07","current":-1.064093,"twenty":-7.561309,"median":-3.979207,"eighty":-1.20312,"marketCap":61790391},{"date":"2025-02-14","current":-0.994579,"twenty":-7.536885,"median":-3.968026,"eighty":-1.196414,"marketCap":57753833},{"date":"2025-02-21","current":-0.914371,"twenty":-7.521503,"median":-3.9572,"eighty":-1.17549,"marketCap":53096266},{"date":"2025-02-28","current":-0.892982,"twenty":-7.492892,"median":-3.932768,"eighty":-1.164843,"marketCap":51854248},{"date":"2025-03-07","current":-0.807427,"twenty":-7.444909,"median":-3.863096,"eighty":-1.158283,"marketCap":46886176},{"date":"2025-03-14","current":-0.823469,"twenty":-7.414105,"median":-3.842071,"eighty":-1.144301,"marketCap":47817689},{"date":"2025-03-21","current":-0.882288,"twenty":-7.351355,"median":-3.83198,"eighty":-1.141087,"marketCap":51233239},{"date":"2025-03-28","current":-0.976018,"twenty":-7.269298,"median":-3.811457,"eighty":-1.130407,"marketCap":59572838},{"date":"2025-04-04","current":-0.887824,"twenty":-7.236716,"median":-3.801177,"eighty":-1.115426,"marketCap":54189750},{"date":"2025-04-11","current":-0.729074,"twenty":-7.230193,"median":-3.789261,"eighty":-1.103846,"marketCap":44500192},{"date":"2025-04-17","current":-0.734953,"twenty":-7.179577,"median":-3.774363,"eighty":-1.086551,"marketCap":44859065},{"date":"2025-04-25","current":-0.858426,"twenty":-7.067737,"median":-3.746951,"eighty":-1.070619,"marketCap":52395387},{"date":"2025-05-02","current":-0.758472,"twenty":-6.968014,"median":-3.738989,"eighty":-1.063486,"marketCap":46294555},{"date":"2025-05-09","current":-0.691313,"twenty":-6.896128,"median":-3.72879,"eighty":-1.048324,"marketCap":42705829},{"date":"2025-05-16","current":-0.74855,"twenty":-6.859478,"median":-3.718608,"eighty":-1.042704,"marketCap":46241627},{"date":"2025-05-23","current":-0.844668,"twenty":-6.802547,"median":-3.708154,"eighty":-1.037357,"marketCap":52179267},{"date":"2025-05-30","current":-0.987387,"twenty":-6.754216,"median":-3.695933,"eighty":-1.028657,"marketCap":60995764},{"date":"2025-06-06","current":-1.194185,"twenty":-6.724496,"median":-3.676093,"eighty":-1.028657,"marketCap":73770689},{"date":"2025-06-13","current":-1.141758,"twenty":-6.654128,"median":-3.658244,"eighty":-1.036781,"marketCap":70531975},{"date":"2025-06-20","current":-1.613606,"twenty":-6.612475,"median":-3.654984,"eighty":-1.037357,"marketCap":99680394},{"date":"2025-06-27","current":-1.858269,"twenty":-6.583701,"median":-3.641213,"eighty":-1.037357,"marketCap":114794389},{"date":"2025-07-03","current":-2.009726,"twenty":-6.53362,"median":-3.635252,"eighty":-1.04087,"marketCap":124150671},{"date":"2025-07-11","current":-2.522352,"twenty":-6.52094,"median":-3.620168,"eighty":-1.041748,"marketCap":155818089},{"date":"2025-07-18","current":-2.504876,"twenty":-6.474846,"median":-3.596047,"eighty":-1.042513,"marketCap":154738518},{"date":"2025-07-25","current":-2.330118,"twenty":-6.463288,"median":-3.571744,"eighty":-1.042704,"marketCap":143942808},{"date":"2025-08-01","current":-2.003901,"twenty":-6.450149,"median":-3.558444,"eighty":-1.045337,"marketCap":123790814},{"date":"2025-08-08","current":-2.044678,"twenty":-6.445264,"median":-3.543057,"eighty":-1.046971,"marketCap":126309814},{"date":"2025-08-15","current":-1.777103,"twenty":-6.421957,"median":-3.518486,"eighty":-1.047884,"marketCap":110409386},{"date":"2025-08-22","current":-2.706575,"twenty":-6.404194,"median":-3.504905,"eighty":-1.048453,"marketCap":168156400},{"date":"2025-08-29","current":-3.273611,"twenty":-6.396742,"median":-3.485096,"eighty":-1.048697,"marketCap":203385711},{"date":"2025-09-05","current":-3.653269,"twenty":-6.392011,"median":-3.496086,"eighty":-1.051532,"marketCap":226973433},{"date":"2025-09-12","current":-5.493285,"twenty":-6.383596,"median":-3.504905,"eighty":-1.056035,"marketCap":341291555},{"date":"2025-09-19","current":-6.028562,"twenty":-6.373537,"median":-3.518486,"eighty":-1.05924,"marketCap":374547736},{"date":"2025-09-26","current":-8.142907,"twenty":-6.373537,"median":-3.543057,"eighty":-1.061931,"marketCap":505909592},{"date":"2025-10-03","current":-6.646648,"twenty":-6.407203,"median":-3.558444,"eighty":-1.063689,"marketCap":412948704},{"date":"2025-10-10","current":-6.351468,"twenty":-6.407203,"median":-3.571744,"eighty":-1.06666,"marketCap":394609481},{"date":"2025-10-17","current":-5.638963,"twenty":-6.397853,"median":-3.592789,"eighty":-1.069012,"marketCap":350342392},{"date":"2025-10-24","current":-5.730571,"twenty":-6.393562,"median":-3.610209,"eighty":-1.06944,"marketCap":356033875},{"date":"2025-10-31","current":-6.524505,"twenty":-6.405727,"median":-3.627238,"eighty":-1.071208,"marketCap":405360060},{"date":"2025-11-07","current":-6.738256,"twenty":-6.453431,"median":-3.639247,"eighty":-1.073827,"marketCap":418640187},{"date":"2025-11-14","current":-6.565219,"twenty":-6.504741,"median":-3.649093,"eighty":-1.076411,"marketCap":407889608},{"date":"2025-11-21","current":-7.221924,"twenty":-6.538979,"median":-3.656253,"eighty":-1.079078,"marketCap":451344069},{"date":"2025-11-28","current":-7.914154,"twenty":-6.597041,"median":-3.661921,"eighty":-1.083812,"marketCap":494605947},{"date":"2025-12-05","current":-6.91197,"twenty":-6.657384,"median":-3.682825,"eighty":-1.092068,"marketCap":431973079},{"date":"2025-12-12","current":-6.405712,"twenty":-6.657384,"median":-3.695933,"eighty":-1.098009,"marketCap":400333795},{"date":"2025-12-19","current":-5.858127,"twenty":-6.634434,"median":-3.709906,"eighty":-1.101065,"marketCap":366111712},{"date":"2025-12-26","current":-7.035952,"twenty":-6.660962,"median":-3.718608,"eighty":-1.102297,"marketCap":439721475},{"date":"2026-01-02","current":-6.798321,"twenty":-6.738256,"median":-3.726533,"eighty":-1.105394,"marketCap":424870382},{"date":"2026-01-09","current":-4.886939,"twenty":-6.757899,"median":-3.736695,"eighty":-1.106806,"marketCap":305415943},{"date":"2026-01-16","current":-4.793953,"twenty":-6.739485,"median":-3.744117,"eighty":-1.10687,"marketCap":299604646},{"date":"2026-01-23","current":-5.517178,"twenty":-6.738502,"median":-3.771529,"eighty":-1.111148,"marketCap":344803623},{"date":"2026-01-30","current":-5.031584,"twenty":-6.738256,"median":-3.780554,"eighty":-1.112218,"marketCap":314455739},{"date":"2026-02-06","current":-4.669971,"twenty":-6.736715,"median":-3.799573,"eighty":-1.116496,"marketCap":291856250},{"date":"2026-02-13","current":-5.12457,"twenty":-6.689013,"median":-3.803637,"eighty":-1.117565,"marketCap":320267036},{"date":"2026-02-20","current":-5.424192,"twenty":-6.669598,"median":-3.819277,"eighty":-1.120773,"marketCap":338992326},{"date":"2026-02-27","current":-5.155565,"twenty":-6.653805,"median":-3.83525,"eighty":-1.12612,"marketCap":322204135},{"date":"2026-03-06","current":-5.145234,"twenty":-6.628326,"median":-3.860323,"eighty":-1.130407,"marketCap":321558435},{"date":"2026-03-13","current":-6.289319,"twenty":-6.61393,"median":-3.916926,"eighty":-1.132899,"marketCap":352358446},{"date":"2026-03-20","current":-5.608457,"twenty":-6.612399,"median":-3.956689,"eighty":-1.135719,"marketCap":314213220},{"date":"2026-03-27","current":-6.023898,"twenty":-6.6085,"median":-3.966616,"eighty":-1.138307,"marketCap":337488273},{"date":"2026-04-02","current":-6.150838,"twenty":-6.597041,"median":-3.973199,"eighty":-1.14016,"marketCap":344600095},{"date":"2026-04-10","current":-6.53166,"twenty":-6.576308,"median":-3.981126,"eighty":-1.141758,"marketCap":365935561},{"date":"2026-04-17","current":-6.427799,"twenty":-6.581349,"median":-3.986625,"eighty":-1.141758,"marketCap":360116797},{"date":"2026-04-24","current":-7.078888,"twenty":-6.597041,"median":-4.01597,"eighty":-1.142021,"marketCap":396594001},{"date":"2026-05-01","current":-6.051122,"twenty":-6.609782,"median":-4.04597,"eighty":-1.142416,"marketCap":339013469},{"date":"2026-05-08","current":-6.028026,"twenty":-6.597041,"median":-4.066733,"eighty":-1.14317,"marketCap":337719524},{"date":"2026-05-15","current":-5.935642,"twenty":-6.581349,"median":-4.091001,"eighty":-1.144301,"marketCap":332543746},{"date":"2026-05-22","current":-6.203557,"twenty":-6.57278,"median":-4.110253,"eighty":-1.144301,"marketCap":337719524},{"date":"2026-05-29","current":-6.013426,"twenty":-6.564313,"median":-4.113505,"eighty":-1.14537,"marketCap":327368854},{"date":"2026-06-05","current":-5.32414,"twenty":-6.564313,"median":-4.129095,"eighty":-1.149728,"marketCap":289844360},{"date":"2026-06-12","current":-4.896307,"twenty":-6.554883,"median":-4.149422,"eighty":-1.151694,"marketCap":266553296},{"date":"2026-06-18","current":-5.24095,"twenty":-6.53166,"median":-4.177765,"eighty":-1.158283,"marketCap":285315542},{"date":"2026-06-26","current":-5.383561,"twenty":-6.524505,"median":-4.196874,"eighty":-1.158283,"marketCap":293079231},{"date":"2026-07-02","current":-6.001541,"twenty":-6.524505,"median":-4.207873,"eighty":-1.15993,"marketCap":326721880},{"date":"2026-07-10","current":-6.369953,"twenty":-6.524505,"median":-4.219024,"eighty":-1.160868,"marketCap":346778074},{"date":"2026-07-17","current":-5.680667,"twenty":-6.521781,"median":-4.221742,"eighty":-1.163058,"marketCap":309253581},{"date":"2026-07-24","current":-5.217182,"twenty":-6.52094,"median":-4.24012,"eighty":-1.165266,"marketCap":284021594},{"date":"2026-07-31","current":-5.027034,"twenty":-6.487193,"median":-4.246328,"eighty":-1.165266,"marketCap":273670010},{"date":"2026-08-07","current":-5.037876,"twenty":-6.450287,"median":-4.246328,"eighty":-1.165266,"marketCap":288550412},{"date":"2026-08-14","current":-5.873756,"twenty":-6.416237,"median":-4.246328,"eighty":-1.165266,"marketCap":336426490},{"date":"2026-08-21","current":-5.930235,"twenty":-6.401892,"median":-4.246328,"eighty":-1.165266,"marketCap":339661360}],"updateTime":1787468534162},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMRX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649998809","title":"Immuneering initiated with an Overweight at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2649998809","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649998809?lang=en_us&edition=fundamental","pubTime":"2026-07-08 18:55","pubTimestamp":1783508140,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Li Watsek initiated coverage of Immuneering (IMRX) with an Overweight rating and $17 price target Immuneering is developi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immuneering-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immuneering-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649367911","title":"Kalaris Appoints Laurie Keating to Board, Replacing Morana Jovan-embiricos","url":"https://stock-news.laohu8.com/highlight/detail?id=2649367911","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649367911?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:06","pubTimestamp":1783368368,"startTime":"0","endTime":"0","summary":"Kalaris appoints Laurie Keating to board, replacing Morana Jovan-EmbiricosKalaris Therapeutics named Laurie Keating to its board, effective Aug. 1, 2026.Director Morana Jovan-Embiricos will step down ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL5PG1ny:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU0109394709.USD","PBE","IE00BN0W2W23.USD","BK4585","IMRX","LU2210150020.SGD","BK4588","KLRS","LU0320765992.SGD","LU0882574055.USD","LU2210149790.SGD","BK4112","BK4539","LU0889565916.HKD","ALNY","BCDF","BK4548","NDAQ","BK4139","SG9999014005.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","BK4563","LU2095319765.USD","SG9999014013.SGD","LU0114720955.EUR","SG9999014021.USD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646823899","title":"Top Executive Makes Bold Insider Move on Immuneering Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2646823899","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646823899?lang=en_us&edition=fundamental","pubTime":"2026-06-25 10:03","pubTimestamp":1782353022,"startTime":"0","endTime":"0","summary":"New insider activity at Immuneering ( ($IMRX) ) has taken place on June 24, 2026. Immuneering’s President and CEO, Benjamin J. Zeskind, has increas...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-bold-insider-move-on-immuneering-stock-insider-trading-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-bold-insider-move-on-immuneering-stock-insider-trading-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4563","BK4539","IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646284550","title":"Immuneering CEO Benjamin Zeskind Acquires 2,400 Shares for $10,948.08","url":"https://stock-news.laohu8.com/highlight/detail?id=2646284550","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646284550?lang=en_us&edition=fundamental","pubTime":"2026-06-25 04:12","pubTimestamp":1782331939,"startTime":"0","endTime":"0","summary":"Immuneering CEO Benjamin Zeskind acquires 2,400 shares for $10,948.08Immuneering President and CEO Benjamin J. Zeskind bought 2,400 shares of Class A common stock at USD 4.56.Direct holdings rose to 2","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDLbyfC4p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Immuneering CEO Benjamin Zeskind Acquires 2,400 Shares for $10,948.08","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRX","BK4539","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644876760","title":"Immuneering Chief Scientific Officer Brett Matthew Hall buys $25,045 of common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2644876760","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644876760?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:16","pubTimestamp":1781640968,"startTime":"0","endTime":"0","summary":"Immuneering Chief Scientific Officer Brett Matthew Hall bought 6,035 shares of Class A common stock at USD 4.15.Direct ownership rose to 382,531 shares following the purchase.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuneering Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL9nPHWb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Immuneering Chief Scientific Officer Brett Matthew Hall buys $25,045 of common shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","BK4539","IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644461764","title":"Mizuho Securities Reaffirms Their Buy Rating on Immuneering (IMRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644461764","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644461764?lang=en_us&edition=fundamental","pubTime":"2026-06-17 02:15","pubTimestamp":1781633717,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Graig Suvannavejh reiterated a Buy rating on Immuneering today and set a price target of $12.00. Suvannavejh covers the H...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-reaffirms-their-buy-rating-on-immuneering-imrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-reaffirms-their-buy-rating-on-immuneering-imrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MFG","IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643178655","title":"Immuneering Appoints Veteran Biotech Leader as New CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2643178655","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643178655?lang=en_us&edition=fundamental","pubTime":"2026-06-16 04:35","pubTimestamp":1781555732,"startTime":"0","endTime":"0","summary":"An update from Immuneering ( ($IMRX) ) is now available. On June 11, 2026, Immuneering Corporation’s board appointed veteran biotech executive Andr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/immuneering-appoints-veteran-biotech-leader-as-new-cfo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/immuneering-appoints-veteran-biotech-leader-as-new-cfo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","BK4588","BK4581","XBI","BK4139","IMRX","BK4585","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643205782","title":"Immuneering Names Andrew Gengos as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2643205782","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643205782?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:58","pubTimestamp":1781528307,"startTime":"0","endTime":"0","summary":"Immuneering  has named Andrew Gengos as chief financial officer, starting July 16, the company said Monday.Gengos most recently served as CFO and head of corporate development at Terns Pharmaceuticals, the company said.He previously served as CFO and chief business officer of Athira Pharma, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMRX","BK4539","BK4563","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643082002","title":"Immuneering Names Andrew Gengos Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2643082002","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643082002?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:53","pubTimestamp":1781524380,"startTime":"0","endTime":"0","summary":"Immuneering has hired Andrew Gengos as the late-stage clinical oncology company's new chief financial officer.Immuneering on Monday said Gengos most recently served as finance chief and head of corporate development at Terns Pharmaceuticals, which Merck & Co. acquired last month.Mallory Morales, Immuneering's senior vice president of finance, chief accounting officer and treasurer, has been serving as the Cambridge, Mass., company's principal financial and accounting officer.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","IMRX","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643083122","title":"Immuneering - Appoints Andrew Gengos as Chief Financial Officer Effective July 16, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643083122","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643083122?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:30","pubTimestamp":1781523001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA5VT9QB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4539","BK4139","IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643520833","title":"Press Release: Immuneering Appoints Andrew Gengos as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2643520833","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643520833?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:30","pubTimestamp":1781523000,"startTime":"0","endTime":"0","summary":"- Former CFO of Terns Pharmaceuticals to join Immuneering -. \"Andrew is a proven biotechnology executive with a strong track record of helping innovative companies navigate critical stages of growth and value creation,\" said Ben Zeskind, Ph.D., Co-Founder and Chief Executive Officer of Immuneering. \"His experience as a CFO, business development leader, and strategic advisor will be invaluable as we advance our clinical programs and prepare for the next phase of Immuneering's growth. We are delighted to welcome Andrew to our leadership team.\". \"I am thrilled to join Immuneering at such an exciting time in the company's development,\" said Andrew Gengos. \"Atebimetinib is now a Phase 3 candidate in first-line pancreatic cancer, supported by recently presented survival and tolerability data that are highly encouraging in a disease where new treatment options are urgently needed. A growing body of data supports the potential of Immuneering's differentiated deep cyclic inhibitor technology to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","IMRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642423703","title":"Immuneering Shareholders Approve Directors and Auditor at Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642423703","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642423703?lang=en_us&edition=fundamental","pubTime":"2026-06-12 06:58","pubTimestamp":1781218732,"startTime":"0","endTime":"0","summary":"Immuneering ( ($IMRX) ) has shared an update. Immuneering Corporation held its Annual Meeting of Stockholders on June 11, 2026, with 44,495,059 Cla...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/immuneering-shareholders-approve-directors-and-auditor-at-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/immuneering-shareholders-approve-directors-and-auditor-at-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMRX","BK4139","BK4563","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642341284","title":"Immuneering's Phase 3 Trial of Atebimetinib Plus mGnP to Treat Pancreatic Cancer Doses First Patient","url":"https://stock-news.laohu8.com/highlight/detail?id=2642341284","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642341284?lang=en_us&edition=fundamental","pubTime":"2026-06-11 20:24","pubTimestamp":1781180654,"startTime":"0","endTime":"0","summary":"Immuneering  said Thursday that the first patient has been dosed in a phase 3 trial of atebimetinib plus modified gemcitabine/nab-paclitaxel to treat pancreatic cancer.The oncology company said the trial is evaluating the safety and efficacy of atebimetinib + mGnP in patients with metastatic pancreatic ductal adenocarcinoma who have received no prior systemic anti-cancer therapy.Chief Executive Ben Zeskind said in a statement that the company intends to initiate more sites and dose more patients, and that topline data are expected in mid-2028.Shares of Immuneering were up 3.4% pre-bell.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4563","BK4539","IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642289490","title":"Immuneering doses first patient in Phase 3 MAPKeeper 301 trial for first-line metastatic pancreatic cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2642289490","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642289490?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:33","pubTimestamp":1781177629,"startTime":"0","endTime":"0","summary":"Immuneering dosed the first patient in MAPKeeper 301, a global pivotal Phase 3 trial in first-line metastatic pancreatic cancer.The study tests atebimetinib with modified gemcitabine and nab-paclitaxel versus standard gemcitabine and nab-paclitaxel alone.Earlier survival and tolerability results were presented this year, supporting the move into a registrational trial.Topline Phase 3 results, including overall survival, are expected in mid-2028.The readout will guide whether atebimetinib can support a new first-line option in a high-need market.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuneering Corporation published the original content used to generate this news brief on June 11, 2026, and is solely responsible for the inform","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDLb9JttN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRX","BK4563","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642289148","title":"Immuneering - Topline Data From Phase 3 Trial Expected in Mid-2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2642289148","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642289148?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:30","pubTimestamp":1781177400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nTUA16QSGN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4563","BK4539","IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640103759","title":"Immuneering Buy Rating Reaffirmed as Analyst Sees ASCO Sell-Off as Overdone; $11 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2640103759","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640103759?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:37","pubTimestamp":1780400229,"startTime":"0","endTime":"0","summary":"Immuneering, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ami Fadia from Needham maintained a Buy rating on...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/immuneering-buy-rating-reaffirmed-as-analyst-sees-asco-sell-off-as-overdone-11-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/immuneering-buy-rating-reaffirmed-as-analyst-sees-asco-sell-off-as-overdone-11-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640960255","title":"Immuneering Advances Atebimetinib With Positive Phase 2a Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2640960255","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640960255?lang=en_us&edition=fundamental","pubTime":"2026-06-02 06:49","pubTimestamp":1780354197,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Immuneering ( ($IMRX) ). On June 1, 2026, Immuneering reported updated Phase 2a data for atebimetinib, a once-d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/immuneering-advances-atebimetinib-with-positive-phase-2a-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/immuneering-advances-atebimetinib-with-positive-phase-2a-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","BK4139","BK4539","IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640962173","title":"Immuneering - 17.3 Month Median Overall Survival Observed in 320 Mg ITT Population as of April 24, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640962173","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640962173?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:52","pubTimestamp":1780347175,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN4290J3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMRX","BK4539","BK4563","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640296214","title":"Immuneering - Announces Updated Phase 2a Data for Atebimetinib in Pancreatic Cancer - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640296214","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640296214?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:52","pubTimestamp":1780347175,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN4290J3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMRX","BK4539","BK4563","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640956718","title":"Immuneering says atebimetinib plus chemo posts 17.3-month median survival in Phase 2a first-line pancreatic cancer study","url":"https://stock-news.laohu8.com/highlight/detail?id=2640956718","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640956718?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:35","pubTimestamp":1780313738,"startTime":"0","endTime":"0","summary":"Immuneering highlighted Phase 2a results already presented at the 2026 ASCO meeting for atebimetinib with chemotherapy in first-line metastatic pancreatic cancer.Patients lived longer than historical outcomes on standard chemotherapy, with responses consistent across cohorts despite different follow-up durations.The regimen showed favorable tolerability, with severe treatment-related side effects largely tied to chemotherapy rather than atebimetinib.A global Phase 3 MAPKeeper 301 trial is recruiting, with first patient dosing expected in mid-2026 to confirm the survival benefit.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuneering Corporation published the original content used to generate this news brief on June 01, 2026, and is","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDLbymZrg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","IMRX","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":88,"code":"91000000","status":"200"}]}}